INSTIL BIO INC's ticker is TIL and the CUSIP is 45783C101. A total of 72 filers reported holding INSTIL BIO INC in Q1 2023. The put-call ratio across all filers is 0.08 and the average weighting 1.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $51,608 | +4.9% | 78,100 | 0.0% | 0.00% | – |
Q4 2022 | $49,203 | -95.0% | 78,100 | -61.6% | 0.00% | – |
Q3 2022 | $985,000 | +9.3% | 203,580 | +4.4% | 0.00% | – |
Q2 2022 | $901,000 | -97.3% | 194,980 | -93.8% | 0.00% | -100.0% |
Q1 2022 | $33,908,000 | -35.2% | 3,154,270 | +3.2% | 0.01% | -27.8% |
Q4 2021 | $52,319,000 | +3.3% | 3,057,792 | +7.9% | 0.02% | -10.0% |
Q3 2021 | $50,653,000 | -8.0% | 2,833,725 | -0.6% | 0.02% | -9.1% |
Q2 2021 | $55,063,000 | +8.6% | 2,850,049 | +41.0% | 0.02% | 0.0% |
Q1 2021 | $50,705,000 | – | 2,021,728 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Curative Ventures V LLC | 37,980,073 | $16,255,471 | 100.00% |
CPMG Inc | 8,218,467 | $3,517,504 | 1.92% |
Western Standard LLC | 1,796,987 | $769,110 | 0.70% |
Vivo Capital, LLC | 12,486,787 | $5,344,345 | 0.59% |
Nantahala Capital Management | 1,000,000 | $428,000 | 0.04% |
Baker Brothers Advisors | 4,704,395 | $2,013,481 | 0.01% |
HCR Wealth Advisors | 40,000 | $17,120 | 0.00% |
Hennion & Walsh Asset Management, Inc. | 98,080 | $41,978 | 0.00% |
Long Focus Capital Management, LLC | 100,000 | $42,800 | 0.00% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 867,279 | $371,195 | 0.00% |